BLUE PEARL TEXSPIN | BALAXI PHARMA | BLUE PEARL TEXSPIN/ BALAXI PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 566.1 | -123.7 | - | View Chart |
P/BV | x | - | 3.7 | - | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
BLUE PEARL TEXSPIN BALAXI PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
BLUE PEARL TEXSPIN Mar-23 |
BALAXI PHARMA Mar-23 |
BLUE PEARL TEXSPIN/ BALAXI PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 36 | 706 | 5.0% | |
Low | Rs | 25 | 304 | 8.4% | |
Sales per share (Unadj.) | Rs | 8.6 | 330.5 | 2.6% | |
Earnings per share (Unadj.) | Rs | -0.3 | 45.2 | -0.6% | |
Cash flow per share (Unadj.) | Rs | -0.3 | 46.9 | -0.6% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | -4.5 | 169.5 | -2.6% | |
Shares outstanding (eoy) | m | 0.26 | 10.18 | 2.6% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 3.5 | 1.5 | 228.5% | |
Avg P/E ratio | x | -107.6 | 11.2 | -962.5% | |
P/CF ratio (eoy) | x | -107.6 | 10.8 | -999.2% | |
Price / Book Value ratio | x | -6.7 | 3.0 | -225.4% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 8 | 5,139 | 0.2% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 0 | 290 | 0.1% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 2 | 3,364 | 0.1% | |
Other income | Rs m | 0 | 26 | 0.0% | |
Total revenues | Rs m | 2 | 3,391 | 0.1% | |
Gross profit | Rs m | 0 | 574 | -0.0% | |
Depreciation | Rs m | 0 | 18 | 0.0% | |
Interest | Rs m | 0 | 14 | 0.0% | |
Profit before tax | Rs m | 0 | 569 | -0.0% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 0 | 110 | 0.0% | |
Profit after tax | Rs m | 0 | 460 | -0.0% | |
Gross profit margin | % | -3.2 | 17.1 | -18.8% | |
Effective tax rate | % | 0 | 19.3 | -0.0% | |
Net profit margin | % | -3.2 | 13.7 | -23.6% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 2 | 1,935 | 0.1% | |
Current liabilities | Rs m | 3 | 531 | 0.6% | |
Net working cap to sales | % | -62.4 | 41.7 | -149.7% | |
Current ratio | x | 0.6 | 3.6 | 15.2% | |
Inventory Days | Days | 35 | 2 | 1,658.8% | |
Debtors Days | Days | 1,348,184 | 567 | 237,685.5% | |
Net fixed assets | Rs m | 0 | 462 | 0.0% | |
Share capital | Rs m | 3 | 102 | 2.5% | |
"Free" reserves | Rs m | -4 | 1,624 | -0.2% | |
Net worth | Rs m | -1 | 1,726 | -0.1% | |
Long term debt | Rs m | 0 | 9 | 0.0% | |
Total assets | Rs m | 2 | 2,397 | 0.1% | |
Interest coverage | x | 0 | 42.3 | - | |
Debt to equity ratio | x | 0 | 0 | -0.0% | |
Sales to assets ratio | x | 1.1 | 1.4 | 81.9% | |
Return on assets | % | -3.7 | 19.8 | -18.7% | |
Return on equity | % | 6.2 | 26.6 | 23.2% | |
Return on capital | % | 6.2 | 33.6 | 18.4% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 802 | 0.0% | |
Fx outflow | Rs m | 0 | 40 | 0.0% | |
Net fx | Rs m | 0 | 763 | 0.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 0 | 61 | -0.8% | |
From Investments | Rs m | NA | -106 | -0.0% | |
From Financial Activity | Rs m | 1 | 255 | 0.2% | |
Net Cashflow | Rs m | 0 | 210 | 0.0% |
Indian Promoters | % | 0.1 | 66.9 | 0.2% | |
Foreign collaborators | % | 19.5 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 17.2 | 0.1% | |
FIIs | % | 0.0 | 17.2 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 80.3 | 33.1 | 242.4% | |
Shareholders | 8,401 | 5,206 | 161.4% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare BLUE PEARL TEXSPIN With: ADANI ENTERPRISES REDINGTON MMTC SIRCA PAINTS INDIA BLACK ROSE IND
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | E-WHA FOAM (I) | BALAXI PHARMA |
---|---|---|
1-Day | 0.00% | 1.68% |
1-Month | 4.98% | 18.41% |
1-Year | 25.40% | 9.82% |
3-Year CAGR | 59.11% | -0.13% |
5-Year CAGR | 27.07% | 45.18% |
* Compound Annual Growth Rate
Here are more details on the E-WHA FOAM (I) share price and the BALAXI PHARMA share price.
Moving on to shareholding structures...
The promoters of E-WHA FOAM (I) hold a 19.7% stake in the company. In case of BALAXI PHARMA the stake stands at 66.9%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of E-WHA FOAM (I) and the shareholding pattern of BALAXI PHARMA.
Finally, a word on dividends...
In the most recent financial year, E-WHA FOAM (I) paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.
BALAXI PHARMA paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of E-WHA FOAM (I), and the dividend history of BALAXI PHARMA.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.